Indian schools record 100% pass rate; more toppers likely after phase 2 improvement exam Dubai: The CBSE Class 10 board examination results for 2026 (Phase 1) have delivered a historic moment for ...

JAC Class 9 Results 2026: Jharkhand Academic Council has announced the Jharlhand 9th result 2026. Candidates who have appeared for their Jharkhand Board 9th exams can check their results through the ...

In a recent survey from the Digital Education Council, a global alliance of universities and industry representatives focused on education innovation, the majority of students (86%) said they use ...

Ijaj Khan is a Senior Tech Journalist and Content Producer at Live Mint, where he translates the fast-paced world of consumer tech, gaming, and AI into stories that spark curiosity and connection.

TheServerSide has published a number of articles on the tenets of effective RESTful web service design, along with examples of how to actually create a cloud-native application using Spring Boot and ...

Looking for workarounds in required writing courses is nothing new for college students. Those trying to avoid writing essays and reports could always buy them. It was expensive and risky: Would the ...

Attaining UFC gold is the ultimate prize for the amazing fighters who climb inside the UFC’s Octagon. But some UFC athletes dare to dream even bigger. Since the UFC began awarding title belts in ...

Government plans to make inheritance tax due on pensions, plus other changes to IHT rules, have seen a leap in people enquiring about the use of trusts to protect their wealth. So what are trusts, and ...

More families are being dragged into paying inheritance tax (IHT), but Brits can lower the bill for their loved ones through a legal loophole known as the seven year rule. Put simply, it means you can ...

In a world of microservices development and Docker-based deployments, RESTful web services tend to grab all the headlines. However, there's still a place in modern enterprise architectures for ...

Venous thromboembolism in patients on check point inhibitors. A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors. This is an ASCO Meeting ...